Zantac is STILL on the shelves in the US despite worldwide recalls
Despite global recalls, brand-name Zantac is sold by a different company - Sanofi - in the US, and neither the drug maker or the FDA have issued a recall of the popular heartburn medication.
Peter Denson, 66, a retired coach engineer from Kent, suffered 20 years of seemingly harmless hiccups, burping and heartburn. He was shocked to be diagnosed with oesophageal cancer.
MONDAY, Oct. 21, 2019 -- The over-the-counter heartburn drug Zantac (ranitidine) has been recalled in the United States and Canada by French drug maker Sanofi. The recall comes a month after the U.S. Food and Drug Administration first warned that...
The U.S. Food and Drug Administration and international health authorities are investigating the safety of Zantac heartburn medicine, also sold generically as ranitidine, after finding a probable cancer-causing impurity in the drug.
Health Canada said it was investigating the possible presence of a carcinogen in some ranitidine drugs available by prescription and over-the-counter.
When heartburn is refractory to proton-pump inhibitor (PPI) treatment, antireflux surgery is a better option than reflux-reducing medication such as baclofen or treatment with neuromodulators, a new clinical trial shows.Reuters Health Information
(AP) — Drugmaker Sanofi is recalling its over-the-counter heartburn drug Zantac in the U.S. and Canada because of possible contamination. The French company Friday joined other drugmakers that have recently recalled their versions of the popular heartburn and ulcer drug. In September, the Food and Drug Administration said a potentially cancer-causing chemical had been detected at low levels in prescription and over-the-counter versions of Zantac. The federal agency said consumers could consider taking another heartburn medicine or contact their doctor. Several drugstore chains have already removed Zantac and generic ...
Drugmaker Sanofi latest to recall over-the-counter heartburn drug Zantac because of possible contamination
Sanofi SA said on Friday it would recall popular heartburn medicine Zantac in the United States and Canada, after the medicines were linked with a probable cancer-causing impurity.
The company ’s announcement follows decisions by Walgreens, CVS and others to remove the drug from their shelves and after other manufacturers recalled their products.
An alert was today circulated by the British medicines watchdog on behalf of Teva UK whose product may have been contaminated with N-nitrosodimethylamine (NDMA).